Kathryn Lipford,Danielle Falcone,David L. Sloman,David J. Witter
申请号：
US15103893
公开号：
US20160311819A1
申请日:
2014.12.12
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed are the ERK inhibitors of formula (1.0) and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0). This invention provides compounds that are ERK inhibitors (i.e., ERK2 inhibitors). This invention also provides a pharmaceutical composition comprising an effective amount of at least one (e.g., 1) compound of formula (1.0) and a pharmaceutically acceptable carrier.
